2024
DOI: 10.1016/j.csbj.2023.12.028
|View full text |Cite
|
Sign up to set email alerts
|

Experimental and computational biophysics to identify vasodilator drugs targeted at TRPV2 using agonists based on the probenecid scaffold

Èric Catalina-Hernández,
Mario López-Martín,
David Masnou-Sánchez
et al.
Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

1
1
0

Year Published

2024
2024
2024
2024

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(2 citation statements)
references
References 41 publications
1
1
0
Order By: Relevance
“…EV2A–O ). In agreement with a recent study on TRPV2 (Catalina-Hernandez et al, 2024 ), we also observed an activation and sensitization of rTRPV2 by benzoic acid (Fig EV2P–S ). However, the non-deprotonatable β-hydroxybutyric acid failed to activate rTRPV2 (Appendix Fig.…”
Section: Resultssupporting
confidence: 93%
See 1 more Smart Citation
“…EV2A–O ). In agreement with a recent study on TRPV2 (Catalina-Hernandez et al, 2024 ), we also observed an activation and sensitization of rTRPV2 by benzoic acid (Fig EV2P–S ). However, the non-deprotonatable β-hydroxybutyric acid failed to activate rTRPV2 (Appendix Fig.…”
Section: Resultssupporting
confidence: 93%
“…Although HOAc-sensitivity was almost abolished in the rTRPV1-H521A mutant, further binding sites may be involved. To this end, a recent study suggested that activation of TRPV2 by probenecid and benzoic acid derivatives may be due to an interaction with the proposed binding sites of the TRPV2-inhibitor piperlongumine, including the residue Arg539 (Catalina-Hernandez et al, 2024 ; Conde et al, 2021 ). While 2-APB-sensitivity of rTRPV2 only partially depends on His521, a stronger reduction of the 2-APB-sensitivity was observed in the double mutant rTRPV2-H521A/R539K (Pumroy et al, 2022 ).…”
Section: Discussionmentioning
confidence: 99%